Barclays Maintains Rating And Raises Price Target On Amgen Inc. (AMGN)

Cornelia Mascio
Ottobre 13, 2017

Fdx Advsrs holds 50,883 shares. Main Street Research Llc who had been investing in Amgen Inc for a number of months, seems to be less bullish one the $133.36 billion market cap company.

The stock decreased 0.88% or $1.64 during the last trading session, reaching $184.15. About shares traded. Amgen, Inc. It has underperformed by 11.43% the S&P500. (QNST) stake by 3.33% reported in 2017Q2 SEC filing. The company has market cap of $4.38 billion.

Among 22 analysts covering Amgen Inc. The stock increased 0.56% or $0.27 during the last trading session, reaching $48.75. About 55,959 shares traded. It has outperformed by 19.10% the S&P500. Jackson Grant Investment Advisers Inc. lifted its holdings in Amgen by 0.6% in the 1st quarter. It is positive, as 31 investors sold VRTX shares while 154 reduced holdings. 24 funds opened positions while 63 raised stakes. As of the last earnings report the EPS was $10.98 and is expected to be $12.58 for the current year with 729,674,000 shares presently outstanding. M&R Capital Inc has invested 0% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Ashford Management Inc reported 0.21% in Balchem Corporation (NASDAQ:BCPC). State Board Of Administration Of Florida Retirement stated it has 368,155 shares. The short-interest ratio decreased to 3.0 and the short interest percentage is 0.01% as of September 15. Highland Mngmt Limited invested in 15,210 shares. Calamos Advsr Ltd Co stated it has 28,207 shares or 0.03% of all its holdings. In that case, its shares would mark a 1.24% decline from the most recent price. Parsec Financial Management Inc.'s holdings in Amgen were worth $21,625,000 at the end of the most recent reporting period. 6,133 were accumulated by Cleararc Capital Inc. Carret Asset Mngmt Ltd Limited Liability Company, a New York-based fund reported 5,571 shares. Stillwater Investment Management, LLC grew its ownership by buying 76 shares an increase of 0.5%. Royal Bancshares Of Canada invested 0% in Ecology and Environment (NASDAQ:EEI).

Since May 1, 2017, it had 0 insider buys, and 2 insider sales for $49,716 activity. River Wealth Advisors LLC now owns 14,772 shares of the medical research company's stock worth $2,544,000 after purchasing an additional 66 shares during the last quarter. $654,015 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was sold by Chodakewitz Jeffrey on Thursday, June 1. The insider BALTIMORE DAVID sold 3,700 shares worth $569,541. It also reduced Lockheed Martin Corp (NYSE:LMT) stake by 1,535 shares and now owns 47,991 shares. Legacy Capital Partners reported 0.41% of its portfolio in Amgen, Inc. One analyst has rated the stock with a sell rating, ten have assigned a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company's stock. Therefore 0 are positive. Vertex Pharmaceuticals had 71 analyst reports since July 31, 2015 according to SRatingsIntel.

07/26/2017 - Amgen Inc. was downgraded to "market perform" by analysts at BMO Capital Markets. Mizuho restated a "buy" rating and set a $195.00 price objective on shares of Amgen in a report on Sunday, July 9th. The firm has "Hold" rating by Vetr given on Monday, August 24. The stock has "Neutral" rating by Citigroup on Wednesday, September 28. The rating was initiated by Credit Suisse on Wednesday, January 20 with "Outperform". Cowen & Co maintained Amgen, Inc.

Short traders are more bearish on the company recently if you evaluate the rise in short interest. Cranbrook Wealth Mgmt Limited Liability Company has invested 0.01% in Amgen, Inc. TrimTabs Asset Management LLC lifted its holdings in Amgen by 88.9% in the 1st quarter. Amgen, Inc. (NASDAQ:AMGN) has risen 5.27% since October 12, 2016 and is uptrending. (AMGN) Stock Has Plenty More Upside" with publication date: "September 27, 2017. A statistical measure of the dispersion of returns (volatility) for AMGN producing salvation in Investors mouth, it has week volatility of 1.78% and for the month booked as 1.65%. Its down 0.10, from 1.25 in 2017Q1. It fall, as 72 investors sold AMGN shares while 463 reduced holdings. 100 funds opened positions while 517 raised stakes. The medical research company reported $3.27 earnings per share for the quarter, beating analysts' consensus estimates of $3.11 by $0.16. (NASDAQ:AMGN). Bb&T Corporation invested in 0.3% or 87,248 shares. Aberdeen Asset Plc Uk reported 848,944 shares. Moreover, Amp Cap Investors Ltd has 0.36% invested in Amgen, Inc. (NASDAQ:AMGN). 7,178 were reported by Private Trust Na. Pinnacle Fincl Prtnrs reported 0.93% of its portfolio in Amgen, Inc. (NASDAQ:AMGN). Bridges Mngmt Inc has 39,098 shares. Fifth Third Bancorp holds 0% or 2,377 shares in its portfolio. Hartline Inv Corp holds 0.58% or 10,538 shares. Its down 9.09% from 1,100 shares previously.

Support is likely to come between $53.58 a share to $53.25 a share level. Altavista Wealth Management Inc holds 0.33% of its portfolio in Amgen, Inc. (NASDAQ:CONE) stake by 10,356 shares and now owns 41,004 shares. Amgen Inc. had 64 analyst reports since August 3, 2015 according to SRatingsIntel.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE